139 related articles for article (PubMed ID: 26124922)
1. RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker.
Jin Y; Cao B; Zhang M; Zhan Q; Herman JG; Yu M; Guo M
Genes Cancer; 2015 May; 6(5-6):231-40. PubMed ID: 26124922
[TBL] [Abstract][Full Text] [Related]
2. Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer.
Dong T; Zhang M; Dong Y; Herman JG; van Engeland M; Zhong G; Guo M
Discov Med; 2015 Nov; 20(111):261-71. PubMed ID: 26645898
[TBL] [Abstract][Full Text] [Related]
3. RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel.
Guo J; Yang Y; Yang Y; Linghu E; Zhan Q; Brock MV; Herman JG; Zhang B; Guo M
Oncotarget; 2015 Feb; 6(6):4202-13. PubMed ID: 25638156
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
[TBL] [Abstract][Full Text] [Related]
5. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
Fan C; Wang W; Jin J; Yu Z; Xin X
Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
[TBL] [Abstract][Full Text] [Related]
6. Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma.
Guo Y; Peng Y; Gao D; Zhang M; Yang W; Linghu E; Herman JG; Fuks F; Dong G; Guo M
Clin Epigenetics; 2017; 9():116. PubMed ID: 29075359
[TBL] [Abstract][Full Text] [Related]
7. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
[TBL] [Abstract][Full Text] [Related]
8. Ras-association domain family 10 acts as a novel tumor suppressor through modulating MMP2 in hepatocarcinoma.
Liu W; Wang J; Wang L; Qian C; Qian Y; Xuan H; Zhuo W; Li X; Yu J; Si J
Oncogenesis; 2016 Jun; 5(6):e237. PubMed ID: 27348267
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.
Li H; Zhang M; Linghu E; Zhou F; Herman JG; Hu L; Guo M
Clin Epigenetics; 2018 Nov; 10(1):137. PubMed ID: 30400968
[TBL] [Abstract][Full Text] [Related]
10. The Tumor Suppressor Role of the Ras Association Domain Family 10.
Hou Y; Li S; Du W; Li H; Wen R
Anticancer Agents Med Chem; 2020; 20(18):2207-2215. PubMed ID: 32664845
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of RASSF10 promotes tumor growth in esophageal squamous cell carcinoma.
Lu D; Ma J; Zhan Q; Li Y; Qin J; Guo M
Discov Med; 2014 Apr; 17(94):169-78. PubMed ID: 24759621
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer.
Richter AM; Walesch SK; Dammann RH
Cancers (Basel); 2016 Feb; 8(3):. PubMed ID: 26927176
[TBL] [Abstract][Full Text] [Related]
14. ZNF545 suppresses human hepatocellular carcinoma growth by inhibiting NF-kB signaling.
Yang W; Yang S; Zhang M; Gao D; He T; Guo M
Genes Cancer; 2017 Mar; 8(3-4):528-535. PubMed ID: 28680537
[TBL] [Abstract][Full Text] [Related]
15. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
Li X; Liang Q; Liu W; Zhang N; Xu L; Zhang X; Zhang J; Sung JJ; Yu J
Oncogene; 2016 May; 35(19):2453-64. PubMed ID: 26279301
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.
Hu S; Cao B; Zhang M; Linghu E; Zhan Q; Brock MV; Herman JG; Mao G; Guo M
Am J Cancer Res; 2015; 5(2):651-62. PubMed ID: 25973304
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer.
Richter AM; Walesch SK; Würl P; Taubert H; Dammann RH
Oncogenesis; 2012 Jun; 1(6):e18. PubMed ID: 23552700
[TBL] [Abstract][Full Text] [Related]
18. RASSF10 is epigenetically inactivated and induces apoptosis in lung cancer cell lines.
Wang Y; Ma T; Bi J; Song B; Zhou Y; Zhang C; Gao M
Biomed Pharmacother; 2014 Apr; 68(3):321-6. PubMed ID: 24433832
[TBL] [Abstract][Full Text] [Related]
19. Frequent epigenetic inactivation of RASSF10 in thyroid cancer.
Schagdarsurengin U; Richter AM; Wöhler C; Dammann RH
Epigenetics; 2009 Nov; 4(8):571-6. PubMed ID: 19934646
[TBL] [Abstract][Full Text] [Related]
20. Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway.
Liu W; Li X; Chu ES; Go MY; Xu L; Zhao G; Li L; Dai N; Si J; Tao Q; Sung JJ; Yu J
Hepatology; 2011 Mar; 53(3):843-53. PubMed ID: 21319196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
